Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MLYS Mineralys Therapeutics, Inc.

Not Yet Opened 09-22 16:00:00 EDT

29.40

+1.09

+3.85%

盘后29.30

-0.10-0.34%

19:30 EDT

High29.55	Low28.37	Vol849.46K
Open28.63	D1 Closing28.31	Amplitude4.17%
Mkt Cap2.59B	Tradable Cap1.94B	Total Shares88.16M
T/O24.81M	T/O Rate1.29%	Tradable Shares66.03M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":29.4,"timestamp":1790107200000,"preClose":28.31,"halted":0,"volume":849455,"hourTrading":{"tag":"盘后","latestPrice":29.3,"preClose":29.4,"latestTime":"19:30 EDT","volume":22888,"amount":672848.41,"timestamp":1790119802960,"change":-0.1,"changeRate":-0.003401,"amplitude":0.003741},"delay":0,"changeRate":0.038502296008477564,"floatShares":66025800,"shares":88158500,"eps":-4.37633,"marketStatus":"Not Yet Opened","change":1.09,"latestTime":"09-22 16:00:00 EDT","open":28.63,"high":29.55,"low":28.37,"amount":24809913.261299998,"amplitude":0.041681,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.37633,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790150400000},"marketStatusCode":0,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":28.31,"preHourTrading":{"tag":"盘前","latestPrice":28.32,"preClose":28.31,"latestTime":"08:38 EDT","volume":1225,"amount":34644.337700000004,"timestamp":1790080728306,"change":0.01,"changeRate":0.000353,"amplitude":0.116567},"postHourTrading":{"tag":"盘后","latestPrice":29.3,"preClose":29.4,"latestTime":"19:30 EDT","volume":22888,"amount":672848.41,"timestamp":1790119802960,"change":-0.1,"changeRate":-0.003401,"amplitude":0.003741},"volumeRatio":0.481171,"impliedVol":0.7942,"impliedVolPercentile":0.3586},"requestUrl":"/m/hq/s/MLYS/wiki","defaultTab":"wiki","newsList":[{"id":"2669120714","title":"Mineralys Therapeutics Chief Commercial Officer Eric Warren Disposes of Common Shares Worth USD 209,111.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120714","media":"Reuters","labels":["shareholding","insiderTrades"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2669120714?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:49","pubTimestamp":1790117356,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Chief Commercial Officer Eric Warren disposes of common shares worth USD 209,111.85Mineralys Therapeutics Chief Commercial Officer Eric Warren sold 7,438 shares on Sept. 21, 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL5S6NXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics Chief Commercial Officer Eric Warren Disposes of Common Shares Worth USD 209,111.85","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669198968","title":"Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669198968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669198968?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:05","pubTimestamp":1790021100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA48LYGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668997753","title":"Mineralys Therapeutics Director Daphne Karydas Sells 3,000 Shares for $85,740","url":"https://stock-news.laohu8.com/highlight/detail?id=2668997753","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668997753?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:41","pubTimestamp":1789681316,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics director Daphne Karydas sells 3,000 shares for $85,740Mineralys Therapeutics director Daphne Karydas sold 3,000 common shares at USD 28.58 on Sep. 15, 2026.She exercised stock o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL2gSYPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics Director Daphne Karydas Sells 3,000 Shares for $85,740","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537260","title":"Mineralys Therapeutics Grants Inducement Equity Awards Covering 52,080 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537260","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537260?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:06","pubTimestamp":1788984406,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics grants inducement equity awards covering 52,080 shares to new hiresMineralys granted inducement stock options covering 29,760 shares, plus inducement restricted stock units cove","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL2fRnMs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4112","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014021.USD","BK4139","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","BK4588","BCDF","IE00BQXX3F31.USD","LU2210149790.SGD","LU0314104364.USD","NDAQ","IE00BN0W2V16.EUR","SG9999014013.SGD","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537455","title":"Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537455","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537455?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:05","pubTimestamp":1788984300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7GC4KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751716","title":"Mineralys Therapeutics Joins Wells Fargo Annual Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751716","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662751716?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:02","pubTimestamp":1787745779,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics joins Wells Fargo annual healthcare conference fireside chatMineralys Therapeutics will participate in the Wells Fargo 21st Annual Healthcare Conference in Boston on Sept. 8-10,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLbHj4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014005.SGD","NDAQ","SG9999014013.SGD","BK4112","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","MLYS","BK4585","BK4139","SG9999014021.USD","LU2095319765.USD","IE00B3QW5Z07.USD","BK4588","LU0314104364.USD","SG9999014039.USD","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","IE00B64PRP62.GBP","BCDF","IE00BQXX3D17.EUR","LU2210150020.SGD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662831718","title":"Mineralys Chief Commercial Officer Eric Warren Disposes of 7,437 Common Shares Worth $193,226","url":"https://stock-news.laohu8.com/highlight/detail?id=2662831718","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662831718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:45","pubTimestamp":1787741125,"startTime":"0","endTime":"0","summary":"Mineralys Chief Commercial Officer Eric Warren disposes of 7,437 common shares worth $193,226Mineralys Therapeutics Chief Commercial Officer Eric Warren sold 7,437 common shares on Aug. 21.Sale priced","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1RgTZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Chief Commercial Officer Eric Warren Disposes of 7,437 Common Shares Worth $193,226","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661121126","title":"Why Mineralys Therapeutics (MLYS) Is Getting Fresh Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2661121126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661121126?lang=en_us&edition=fundamental","pubTime":"2026-08-23 00:24","pubTimestamp":1787415872,"startTime":"0","endTime":"0","summary":"Why Mineralys Therapeutics Stock Is In Focus After Earnings And Leadership Change\nMineralys Therapeutics (MLYS) is on investors’ radar after second quarter 2026 results showed a net loss of US$241.07 million, alongside the appointment of James J. Ferguson III, M.D., as Chief Medical Officer.\nSee our latest analysis for Mineralys Therapeutics.\nMineralys Therapeutics’ recent news arrives after a mixed run for investors, with the share price down 5.04% over 30 days and 14.07% over 90 days, yet a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/why-mineralys-therapeutics-mlys-is-getting-fresh-attention","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/why-mineralys-therapeutics-mlys-is-getting-fresh-attention","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660444679","title":"Does New CMO Hire and Heavier Leverage Reshape the Bull Case For Mineralys Therapeutics (MLYS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660444679","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660444679?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:16","pubTimestamp":1787131013,"startTime":"0","endTime":"0","summary":"In August 2026, Mineralys Therapeutics reported a second-quarter net loss of US$241.07 million and a six-month net loss of US$280.41 million, while also appointing veteran cardiologist and drug developer James J. “Terry” Ferguson III, M.D., as its new Chief Medical Officer with his predecessor moving into a full-time advisory role.\nThese developments came as the company advanced its lead therapy lorundrostat toward an expected FDA decision and bolstered its balance sheet with US$150 million...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/does-new-cmo-hire-and-heavier-leverage-reshape-the-bull-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/does-new-cmo-hire-and-heavier-leverage-reshape-the-bull-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162640","title":"Mineralys Grants New CMO Inducement Awards for 135,000 Stock Options, 102,400 RSUs","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162640","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162640?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:06","pubTimestamp":1786651613,"startTime":"0","endTime":"0","summary":"Mineralys grants new CMO inducement awards for 135,000 stock options, 102,400 RSUsMineralys Therapeutics granted new Chief Medical Officer Terry Ferguson inducement equity awards dated Aug. 10, 2026.P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL908CZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162321","title":"Mineralys Therapeutics Reports Inducement Award Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162321?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651504,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2H58QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315159","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619422,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monte Rosa Therapeutics (GLUE), Mineralys Therapeuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","XLV","HCSG","BK4585","LABU","BK4139","GLUE","BK4581","BK4539","MLYS","XBI","BK4137","LU0128526141.USD","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659135482","title":"Mineralys Therapeutics Confronts Heightened Refinancing and Liquidity Risks as 2031 Debt Maturity Looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2659135482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659135482?lang=en_us&edition=fundamental","pubTime":"2026-08-13 14:00","pubTimestamp":1786600839,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics, Inc. (MLYS) has disclosed a new risk, in the Debt & Financing category. Mineralys Therapeutics, Inc. faces material refinan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mineralys-therapeutics-confronts-heightened-refinancing-and-liquidity-risks-as-2031-debt-maturity-looms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mineralys-therapeutics-confronts-heightened-refinancing-and-liquidity-risks-as-2031-debt-maturity-looms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659189827","title":"Mineralys Therapeutics CMO David Malcom Rodman Disposes of USD 58,785.3 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659189827","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659189827?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:33","pubTimestamp":1786577635,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics CMO David Malcom Rodman disposes of USD 58,785.3 in common sharesMineralys Therapeutics Chief Medical Officer Rodman David Malcom exercised stock options for 2,170 shares at USD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4jh0hD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics CMO David Malcom Rodman Disposes of USD 58,785.3 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659189821","title":"Mineralys Therapeutics Names James J. Ferguson III as Chief Medical Officer in Form 3 Beneficial Ownership Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659189821","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659189821?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:33","pubTimestamp":1786577632,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics names James J. Ferguson III as chief medical officer in Form 3 beneficial ownership filingMineralys Therapeutics filed a Form 3 initial beneficial ownership statement for Chief ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbSLqXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658778359","title":"Goldman Sachs Reaffirms Their Buy Rating on Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658778359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658778359?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:20","pubTimestamp":1786537233,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Richard Law CFA maintained a Buy rating on Mineralys Therapeutics, Inc. today and set a price target of $40.00. Law CFA cover...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928337","title":"Mineralys Therapeutics Publishes Corporate Presentation on Lorundrostat for Uncontrolled, Resistant Hypertension and Cardiorenal Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928337","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658928337?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:14","pubTimestamp":1786504440,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics publishes corporate presentation on lorundrostat for uncontrolled, resistant hypertension and cardiorenal diseasesMineralys highlighted FDA acceptance of its NDA for lorundrosta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL2vf24g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945272","title":"Mineralys Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945272","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945272?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:01","pubTimestamp":1786482072,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryMineralys Therapeutics, Inc.MLYS.OQreported a quarterly adjusted loss of $2.85 per share for the quarter en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N448261:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658294596","title":"Mineralys Therapeutics Q2 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2658294596","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658294596?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:46","pubTimestamp":1786481180,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics  reported a Q2 loss late Tuesday of $2.85 per diluted share, widening from a loss of $0.66 a year earlier.Analysts polled by FactSet expected a loss of $0.55.As expected, no revenue was reported for the quarter ended June 30.Cash and cash equivalents as of June 30 were $661.4 million, which is expected to fund operations into 2028, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","MLYS","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658432299","title":"Earnings Flash (MLYS) Mineralys Therapeutics Posts Q2 Loss $2.85, vs. FactSet Est of $0.55 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658432299","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658432299?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:29","pubTimestamp":1786480180,"startTime":"0","endTime":"0","summary":"Earnings Flash (MLYS) Mineralys Therapeutics Posts Q2 Loss $2.85, vs. FactSet Est of $0.55 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MLYS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mineralystx.com;www.ir.mineralystx.com","stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.1037},{"period":"3month","weight":0.1054},{"period":"6month","weight":0.1499},{"period":"1year","weight":-0.2791},{"period":"ytd","weight":-0.2199}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0544},{"period":"6month","weight":0.1776},{"period":"1year","weight":0.1654},{"period":"ytd","weight":0.1343}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.014493},{"month":2,"riseRate":0.333333,"avgChangeRate":0.081442},{"month":3,"riseRate":0.25,"avgChangeRate":0.095856},{"month":4,"riseRate":0,"avgChangeRate":-0.078413},{"month":5,"riseRate":1,"avgChangeRate":0.100473},{"month":6,"riseRate":0.25,"avgChangeRate":-0.046559},{"month":7,"riseRate":0.5,"avgChangeRate":-0.030144},{"month":8,"riseRate":0.75,"avgChangeRate":0.002547},{"month":9,"riseRate":0.5,"avgChangeRate":0.317234},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.001589},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.0429},{"month":12,"riseRate":0.333333,"avgChangeRate":0.032291}],"exchange":"NASDAQ","name":"Mineralys Therapeutics, Inc.","nameEN":"Mineralys Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mineralys Therapeutics, Inc.(MLYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mineralys Therapeutics, Inc.,MLYS,Mineralys Therapeutics, Inc.股票,Mineralys Therapeutics, Inc.股票老虎,Mineralys Therapeutics, Inc.股票老虎国际,Mineralys Therapeutics, Inc.行情,Mineralys Therapeutics, Inc.股票行情,Mineralys Therapeutics, Inc.股价,Mineralys Therapeutics, Inc.股市,Mineralys Therapeutics, Inc.股票价格,Mineralys Therapeutics, Inc.股票交易,Mineralys Therapeutics, Inc.股票购买,Mineralys Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mineralys Therapeutics, Inc.(MLYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}